Dose-dense and metronomic chemotherapy
Two opposite ways of rescheduling the same drugs: dose-dense gives standard doses more often (every two weeks instead of three, supported by growth factors) to deny the tumour recovery time; metronomic gives small doses continuously to attack tumour blood vessels with little toxicity.
Dose-dense adjuvant chemotherapy improved survival in breast cancer (CALGB 9741, EBCTCG meta-analysis) and interval-compressed VDC/IE is standard in Ewing sarcoma; it needs G-CSF support. Metronomic oral chemotherapy (capecitabine, cyclophosphamide, methotrexate, vinorelbine) exploits anti-angiogenic and immune effects, is cheap and well tolerated, and is used in maintenance (CM in triple-negative breast, SYSUCC-001) and low-resource settings such as Tata Memorial's head and neck trials. Both are examples of gaining efficacy from schedule rather than new molecules.
Pages like this
not linked directly; found by shared links- TermFebrile neutropenia
Shares Neutropenia, Growth factors: G-CSF and febrile neutropenia prevention.
- ProductEribulin
Shares Cytotoxic chemotherapy, Sarcomas (soft tissue, bone, GIST), Triple-negative breast cancer (TNBC).
- IdeaA platform trial of very-low-cost metronomic chemotherapy in LMIC common cancers
Shares Cytotoxic chemotherapy, Head and neck squamous cell carcinoma, Triple-negative breast cancer (TNBC).
- TermInduction therapy
Shares Maintenance therapy, Head and neck squamous cell carcinoma.
- IdeaValidate low-cost metronomic oral regimens in phase 3 and carry them into guidelines
Shares Cytotoxic chemotherapy, Head and neck squamous cell carcinoma.
- ProductPegylated liposomal doxorubicin
Shares Cytotoxic chemotherapy, Sarcomas (soft tissue, bone, GIST).
- PairingCaution: cumulative anthracycline dose and the heart
Shares Sarcomas (soft tissue, bone, GIST), Triple-negative breast cancer (TNBC).
- TermDose reduction, interruption and discontinuation
Shares Regimen and cycles, Neutropenia.